Simplex Trading’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-935
Closed -$13.6K 9121
2025
Q1
$20K Buy
+935
New +$22K ﹤0.01% 6583
2024
Q2
Sell
-2,103
Closed -$62.4K 9228
2024
Q1
$74K Buy
+2,103
New +$84.1K ﹤0.01% 5900
2023
Q1
Sell
-6,844
Closed -$383K 9481
2022
Q4
$383K Buy
6,844
+6,753
+7,421% +$344K ﹤0.01% 3461
2022
Q3
$3K Sell
91
-2,974
-97% -$152K ﹤0.01% 9094
2022
Q2
$165K Buy
+3,065
New +$184K ﹤0.01% 4865
2020
Q2
Sell
-103
Closed -$5.06K 7918
2020
Q1
$4K Sell
103
-3,324
-97% -$174K ﹤0.01% 6951
2019
Q4
$199K Buy
+3,427
New +$204K ﹤0.01% 3760
2018
Q2
Sell
-342
Closed -$21.2K 7570
2018
Q1
$18K Buy
342
+7
+2% +$367 ﹤0.01% 3467
2017
Q4
$16K Sell
335
-523
-61% -$25.6K ﹤0.01% 3505
2017
Q3
$43K Buy
+858
New +$44.1K ﹤0.01% 2440
2017
Q2
Sell
-117
Closed -$4K 6398
2017
Q1
$4K Buy
+117
New +$5K ﹤0.01% 4765
2016
Q4
Sell
-7,430
Closed -$302K 6125
2016
Q3
$306K Buy
+7,430
New +$311K 0.02% 760
2015
Q4
Sell
-40
Closed -$1K 5697
2015
Q3
$1K Buy
+40
New +$1.25K ﹤0.01% 5025
2015
Q2
Sell
-159
Closed -$4.24K 5455
2015
Q1
$4K Buy
+159
New +$3.76K ﹤0.01% 3671

Other funds holding IART

Simplex Trading's IART Position: Q2 2025 in Review

Simplex Trading sold out of Integra LifeSciences (IART) in Q2 2025, closing a stake of 935 shares — an estimated $13.6K sold.

Simplex Trading first reported a position in IART in Q1 2015 and held it in 14 quarters. The position peaked at $383K in Q4 2022. 208 funds tracked by Wall St. Rank hold IART as of Q2 2025.

  • Simplex Trading reported no remaining Integra LifeSciences position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 935 Integra LifeSciences shares in Q2 2025, an estimated $13.6K.
  • Simplex Trading first reported a position in Integra LifeSciences in Q1 2015 and held it in 14 quarters.
  • Simplex Trading's Integra LifeSciences position peaked at $383K in Q4 2022.
  • 208 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.